Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 1 August 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 10300395 Dr Andrea Marongiu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10300395 2023-07-31 10300395 2024-07-31 10300395 2023-08-01 2024-07-31 10300395 frs-core:CurrentFinancialInstruments 2024-07-31 10300395 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 10300395 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 10300395 frs-bus:Micro-entities 2023-08-01 2024-07-31 10300395 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 10300395 frs-bus:Director1 2023-08-01 2024-07-31 10300395 2022-07-31 10300395 2023-07-31 10300395 2022-08-01 2023-07-31 10300395 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 10300395
AM Health Enterprise Limited
Financial Statements
For The Year Ended 31 July 2024
Balance Sheet
Registered number: 10300395
2024 2023
£ £
Current assets 12,426 12,727
Creditors: Amounts Falling Due Within One Year (761 ) (761 )
NET CURRENT ASSETS 11,665 11,966
TOTAL ASSETS LESS CURRENT LIABILITIES 11,665 11,966
NET ASSETS 11,665 11,966
CAPITAL AND RESERVES 11,665 11,966

Notes

1. General Information
AM Health Enterprise Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10300395 . The registered office is Flat 9 Alina Court, 58 Lomond Grove, London, SE5 7LE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Andrea Marongiu
Director
20/01/2025